Skip to main content Skip to search Skip to main navigation

At what point may water be used during the performance qualification of a water supply system?

During Phase III or long-term phase, the water can be used for pharmaceutical manufacture. The quality is monitored in accordance with the previously defined sampling plan.

From a regulatory point of view, an "at risk" release is theoretically possible. However, if PQ Phase II is not successfully completed, the products manufactured during this phase must be destroyed.

[GMP Compliance Adviser, Chapter 5.D]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

EMA: New Q&A for Co-Processed Excipients

EMA: New Q&A for Co-Processed Excipients

The EMA has published new Questions & Answers on co-processed excipients (CoPEs) used in solid oral dosage forms, introducing a harmonised, risk-based regulatory approach applicable to human and veterinary medicines.

Read more
EMA: New Q&A on Product Lifecycle Management (PLCM)

EMA: New Q&A on Product Lifecycle Management (PLCM)

The EMA has published new Questions & Answers on the use of the Product Lifecycle Management (PLCM) document, clarifying its role within the EU variations framework for post-approval quality changes.
Read more
What is the Data Lifecycle?

What is the Data Lifecycle?

Here's the answer:
Read more
Previous
Next